Cargando…

Repeated immune activation with low-dose lipopolysaccharide attenuates the severity of Huntington's disease in R6/2 transgenic mice

Huntington's disease (HD) is a neurodegenerative disorder caused by a mutation in the huntingtin gene. Previously, therapeutic approaches using anti-inflammatory agents were reportedly not effective for preventing HD progression. Since whether immune responses contribute to the onset of HD is n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Sung Won, Park, Hyun Jung, Im, Wooseok, Kim, Manho, Hong, Seokmann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138304/ https://www.ncbi.nlm.nih.gov/pubmed/30460101 http://dx.doi.org/10.1080/19768354.2018.1473291

Ejemplares similares

iNKT Cell Activation Exacerbates the Development of Huntington's Disease in R6/2 Transgenic Mice
por: Park, Hyun Jung, et al.
Publicado: (2019)

Cell Therapy Strategies vs. Paracrine Effect in Huntington’s Disease
por: Im, Wooseok, et al.
Publicado: (2014)

Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice
por: Im, Wooseok, et al.
Publicado: (2010)

Extracts of Adipose Derived Stem Cells Slows Progression in the R6/2 Model of Huntington's Disease
por: Im, Wooseok, et al.
Publicado: (2013)

Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington’s disease R6/2 model
por: Im, Wooseok, et al.
Publicado: (2015)

MicroRNA-124 slows down the progression of Huntington’s disease by promoting neurogenesis in the striatum
por: Liu, Tian, et al.
Publicado: (2015)

Exosome-Based Delivery of miR-124 in a Huntington’s Disease Model
por: Lee, Soon-Tae, et al.
Publicado: (2017)

Two-weeks repeated-dose oral toxicity study of Pediococcus acidilactici J9 in a mice model
por: Lee, Mijung, et al.
Publicado: (2020)

Amelioration of Huntington's disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1α deacetylation
por: Lee, Mijung, et al.
Publicado: (2018)

Dendritic Cells as Danger-Recognizing Biosensors
por: Gi, Mia, et al.
Publicado: (2009)

In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington’s Disease
por: Jeon, Iksoo, et al.
Publicado: (2014)

Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders
por: Im, Wooseok, et al.
Publicado: (2016)

Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
por: Petersén, Åsa, et al.
Publicado: (2005)

A Case of Juvenile Huntington Disease in a 6-Year-Old Boy
por: Sunwoo, Jun-Sang, et al.
Publicado: (2010)

Necrostatin-1 ameliorates symptoms in R6/2 transgenic mouse model of Huntington's disease
por: Zhu, S, et al.
Publicado: (2011)

Dysfunctional mitochondrial respiration in the striatum of the Huntington’s disease transgenic R6/2 mouse model
por: Aidt, Frederik Heurlin, et al.
Publicado: (2013)

CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
por: Comella Bolla, Andrea, et al.
Publicado: (2019)

Continuous and Periodic Expansion of CAG Repeats in Huntington's Disease R6/1 Mice
por: Møllersen, Linda, et al.
Publicado: (2010)

CAG Repeat Instability in the Peripheral and Central Nervous System of Transgenic Huntington’s Disease Monkeys
por: Cho, In K., et al.
Publicado: (2022)

Effects of Anthocyanins on CAG Repeat Instability and Behaviour in Huntington’s Disease R6/1 Mice
por: Møllersen, Linda, et al.
Publicado: (2016)

Neurogenic Effects of Cell-Free Extracts of Adipose Stem Cells
por: Ban, Jae-Jun, et al.
Publicado: (2016)

Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients
por: Kim, Ki Yoon, et al.
Publicado: (2020)

Progressive Polyglutamine Repeat Expansion in Peripheral Blood Cells and Sperm of Transgenic Huntington’s Disease Monkeys
por: Clever, Faye, et al.
Publicado: (2019)

Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
por: Park, Jung-Eun, et al.
Publicado: (2013)

Gene Therapy for Huntington’s Disease: The Final Strategy for a Cure?
por: Byun, Seulgi, et al.
Publicado: (2022)

The Ubiquitin-Proteasome Reporter GFPu Does Not Accumulate in Neurons of the R6/2 Transgenic Mouse Model of Huntington's Disease
por: Bett, John S., et al.
Publicado: (2009)

Motor phenotype is not associated with vascular dysfunction in symptomatic Huntington’s disease transgenic R6/2 (160 CAG) mice
por: Di Pardo, A., et al.
Publicado: (2017)

Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington’s disease
por: El-Akabawy, Gehan, et al.
Publicado: (2012)

Graphene oxide polarizes iNKT cells for production of TGFβ and attenuates inflammation in an iNKT cell-mediated sepsis model
por: Lee, Sung Won, et al.
Publicado: (2018)

Suitability of autologous serum for expanding rabbit adipose-derived stem cell populations
por: Bahn, Jae-Jun, et al.
Publicado: (2012)

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
por: Chen, Xi, et al.
Publicado: (2011)

Lessons Learned from the Transgenic Huntington's Disease Rats
por: Vlamings, Rinske, et al.
Publicado: (2012)

Effect of Trinucleotide Repeats in the Huntington's Gene on Intelligence
por: Lee, Jessica K., et al.
Publicado: (2018)

Hunting out the repeat expansion in Huntington’s pigs
por: Yang, Guang, et al.
Publicado: (2023)

Cytosolic Extract of Human Adipose Stem Cells Reverses the Amyloid Beta-Induced Mitochondrial Apoptosis via P53/Foxo3a Pathway
por: Liu, Tian, et al.
Publicado: (2017)

Screening of the A11084G Polymorphism and Scanning of a Mitochondrial Genome SNP in Korean Migraineurs
por: Kang, Lami, et al.
Publicado: (2007)

Therapeutic Effect of Berberine on Huntington’s Disease Transgenic Mouse Model
por: Jiang, Wenxiao, et al.
Publicado: (2015)

Metabolic disruption identified in the Huntington’s disease transgenic sheep model
por: Handley, Renee. R., et al.
Publicado: (2016)

Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy
por: Chang, Renbao, et al.
Publicado: (2015)

Striatal Interneurons in Transgenic Nonhuman Primate Model of Huntington’s Disease
por: Lallani, Shoeb B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ieina3on678q5r73d1372268pu